Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikiko Ohno

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|July 28, 2017
Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndromePo-Min Chen, Mikiko Ohno, Takaki Hiwasa, et al.
Diabetes|July 8, 2016
Nardilysin Is Required for Maintaining Pancreatic β-Cell FunctionKiyoto Nishi, Yuichi Sato, Mikiko Ohno, et al.
JCI Insight|April 20, 2018
Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulationKeitaro Kanda, Jiro Sakamoto, Yoshihide Matsumoto, et al.
Journal of Circulating Biomarkers|September 23, 2017
Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes MellitusTakaki Hiwasa, Xiao-Meng Zhang, Risa Kimura, et al.
Internal and Emergency Medicine|January 17, 2024
Auxiliary roles of nardilysin in the early diagnosis of acute coronary syndrome: a prospective cohort study, the Nardi-ACS studyMikiko Ohno, Hiroki Shiomi, Osamu Baba, et al.
International Journal of Molecular Sciences|May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related DiseasesBo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
Oncotarget|March 7, 2018
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attackYoichi Yoshida, Hao Wang, Takaki Hiwasa, et al.
Heliyon|September 9, 2020
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseasesYoichi Yoshida, Xiao-Meng Zhang, Hao Wang, et al.
Cell|July 19, 2018
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo ProductionYukitaka Ito, Sou Nakamura, Naoshi Sugimoto, et al.
International Journal of Molecular Medicine|September 18, 2020
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertensionShu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|July 28, 2017
Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndromePo-Min Chen, Mikiko Ohno, Takaki Hiwasa, et al.
Diabetes|July 8, 2016
Nardilysin Is Required for Maintaining Pancreatic β-Cell FunctionKiyoto Nishi, Yuichi Sato, Mikiko Ohno, et al.
JCI Insight|April 20, 2018
Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulationKeitaro Kanda, Jiro Sakamoto, Yoshihide Matsumoto, et al.
Journal of Circulating Biomarkers|September 23, 2017
Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes MellitusTakaki Hiwasa, Xiao-Meng Zhang, Risa Kimura, et al.
Internal and Emergency Medicine|January 17, 2024
Auxiliary roles of nardilysin in the early diagnosis of acute coronary syndrome: a prospective cohort study, the Nardi-ACS studyMikiko Ohno, Hiroki Shiomi, Osamu Baba, et al.
International Journal of Molecular Sciences|May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related DiseasesBo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
Oncotarget|March 7, 2018
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attackYoichi Yoshida, Hao Wang, Takaki Hiwasa, et al.
Heliyon|September 9, 2020
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseasesYoichi Yoshida, Xiao-Meng Zhang, Hao Wang, et al.
Cell|July 19, 2018
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo ProductionYukitaka Ito, Sou Nakamura, Naoshi Sugimoto, et al.
International Journal of Molecular Medicine|September 18, 2020
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertensionShu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Pageof 4